Profile | GDS2987 / GI_4758797-S |
Title | Comparison of Rho kinase inhibitor and atorvastatin effects on primary cell lines |
Organism | Homo sapiens |
Sample | Title | Value | Rank |
---|---|---|---|
GSM214810 | HMVEC_vehicle_rep1 | 33.4 | 66 |
GSM215244 | HMVEC_vehicle_rep2 | 23.3 | 50 |
GSM215253 | HMVEC_vehicle_rep3 | 25.3 | 60 |
GSM215254 | HMVEC_atorvastatin_rep1 | 4.5 | 13 |
GSM215282 | HMVEC_atorvastatin_rep3 | ||
GSM215344 | HMVEC_atorvastatin_rep2 | 29.7 | 57 |
GSM215283 | HMVEC_atorvastatin_mevalonate_rep1 | 41.5 | 60 |
GSM215284 | HMVEC_atorvastatin_mevalonate_rep2 | 80.9 | 73 |
GSM215293 | HMVEC_atorvastatin_mevalonate_rep3 | 41 | 55 |
GSM215294 | HMVEC_SLx2119_rep1 | 6.4 | 24 |
GSM215295 | HMVEC_SLx2119_rep2 | 56.2 | 68 |
GSM215296 | HMVEC_SLx2119_rep3 | 34.1 | 49 |
GSM215297 | PASMC_vehicle_rep1 | ||
GSM215298 | PASMC_vehicle_rep2 | 6.2 | 10 |
GSM215310 | PASMC_vehicle_rep3 | ||
GSM215311 | PASMC_atorvastatin_rep1 | ||
GSM215312 | PASMC_atorvastatin_rep2 | 5.3 | 9 |
GSM215313 | PASMC_atorvastatin_rep3 | 9.8 | 15 |
GSM215324 | PASMC_atorvastatin_mevalonate_rep1 | 10.3 | 18 |
GSM215325 | PASMC_atorvastatin_mevalonate_rep2 | ||
GSM215326 | PASMC_atorvastatin_mevalonate_rep3 | ||
GSM215327 | PASMC_SLx2119_rep1 | ||
GSM215328 | PASMC_SLx2119_rep2 | ||
GSM215329 | PASMC_SLx2119_rep3 | ||
GSM215330 | Fibroblasts_vehicle_rep1 | 70 | 71 |
GSM215331 | Fibroblasts_vehicle_rep2 | 92.2 | 74 |
GSM215332 | Fibroblasts_vehicle_rep3 | 89.7 | 74 |
GSM215333 | Fibroblasts_atorvastatin_rep1 | 84.4 | 74 |
GSM215334 | Fibroblasts_atorvastatin_rep2 | 60.7 | 70 |
GSM215335 | Fibroblasts_atorvastatin_rep3 | 95.3 | 74 |
GSM215336 | Fibroblasts_atorvastatin_mevalonate_rep1 | 84.4 | 74 |
GSM215337 | Fibroblasts_atorvastatin_mevalonate_rep2 | 84.6 | 74 |
GSM215338 | Fibroblasts_atorvastatin_mevalonate_rep3 | 76.6 | 73 |
GSM215339 | Fibroblasts_SLx2119_rep1 | 38.2 | 66 |
GSM215340 | Fibroblasts_SLx2119_rep2 | 56.8 | 70 |
GSM215341 | Fibroblasts_SLx2119_rep3 | 78.1 | 73 |